CEMIP and gastric cancer: Again, CEMIP has also been shown to be an independent prognostic factor in NSCLC [19,21], gastric cancer [24,25], pancreatic ductal adenocarcinoma [26], laryngeal squamous cell carcinoma [34], osteosarcoma [36], and HCC [33].